X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-20 | PSEC | Prospect Capital Corp | Barry John F | CEO, 10% | P - Purchase | $3.19 | +623,300 | 83,622,108 | +1% | +$1,988,763 | ||||||
2025-06-20 | CAI | Caris Life Sciences, Inc. | Brille Brian J | See Remarks | P - Purchase | $21.00 | +30,000 | 662,428 | +5% | +$630,000 | ||||||
2025-06-20 | THAR | Tharimmune, Inc. | Gravitas Capital LP | Exec COB, 10% | P - Purchase | $1.48 | +337,838 | 732,424 | +86% | +$500,000 | ||||||
2025-06-18 | OXM | Oxford Industries Inc | Trauber Robert S. | CEO, Johnny Was | P - Purchase | $41.38 | +10,000 | 13,364 | +297% | +$413,750 | ||||||
D | 2025-06-20 | DOMO | Domo, Inc. | James Joshua G | Founder, CEO, 10% | P - Purchase | $12.74 | +13,025 | 1,638,525 | +1% | +$165,897 | |||||
D | 2025-06-20 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | P - Purchase | $21.00 | +7,500 | 128,591 | +6% | +$157,500 | |||||
2025-06-20 | THAR | Tharimmune, Inc. | Appajosyula Sireesh | CEO | P - Purchase | $1.48 | +61,496 | 64,868 | >999% | +$90,973 | ||||||
2025-06-18 | DLTR | Dollar Tree, Inc. | Maheshwari Aditya | Chief Accounting Officer | P - Purchase | $98.20 | +610 | 4,841 | +14% | +$59,899 | ||||||
2025-06-18 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres, CEO, 10% | P - Purchase | $2.39 | +21,000 | 3,197,779 | +1% | +$50,144 | ||||||
M | 2025-06-20 | IMRX | Immuneering Corp | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | P - Purchase | $2.58 | +13,422 | 359,318 | +4% | +$34,616 | |||||
2025-06-20 | MTN | Vail Resorts Inc | Korch Angela A | EVP, CFO | P - Purchase | $157.00 | +200 | 3,156 | +7% | +$31,400 | ||||||
2025-06-24 | RZLT | Rezolute, Inc. | Evans Daron | CFO | P - Purchase | $4.05 | +5,000 | 360,900 | +1% | +$20,250 | ||||||
2025-06-17 | AKTX | Akari Therapeutics Plc | Gaslightwala Abizer | Pres, CEO | P - Purchase | $1.20 | +15,000 | 261,428 | +6% | +$18,000 | ||||||
2025-06-17 | MKTW | Marketwise, Inc. | Mickels Erik | CFO | P - Purchase | $17.94 | +940 | 69,998 | +1% | +$16,864 | ||||||
2025-06-13 | GLBZ | Glen Burnie Bancorp | Hanna Mark Christopher | Pres, CEO | P - Purchase | $4.76 | +3,000 | 16,570 | +22% | +$14,280 | ||||||
2025-06-18 | LAKE | Lakeland Industries Inc | Jenkins James M. | Pres, CEO, Exec. Chair | P - Purchase | $13.14 | +1,000 | 98,262 | +1% | +$13,140 | ||||||
2025-06-20 | AKTX | Akari Therapeutics Plc | Gaslightwala Abizer | Pres, CEO | P - Purchase | $1.20 | +10,000 | 271,428 | +4% | +$12,000 | ||||||
M | 2025-06-20 | MDBH | Mdb Capital Holdings, LLC | Marlett Christopher A | Co-Founder, 10% | P - Purchase | $4.13 | +1,565 | 144,235 | +1% | +$6,457 | |||||
2025-06-23 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | CEO | P - Purchase | $1.14 | +4,350 | 348,470 | +1% | +$4,946 | ||||||
2025-06-20 | IMRX | Immuneering Corp | Brakewood Harold Eugene | Chief Business Officer | P - Purchase | $2.53 | +1,900 | 5,800 | +49% | +$4,804 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |